Stock Yards Bank & Trust Co. reduced its stake in The Clorox Company (NYSE:CLX – Free Report) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,160 shares of the company’s stock after selling 100 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Clorox were worth $3,437,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Catalyst Capital Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter worth about $54,000. Los Angeles Capital Management LLC increased its holdings in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after buying an additional 9,037 shares during the last quarter. Natixis Advisors LLC increased its holdings in shares of Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after buying an additional 13,038 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.
Clorox Price Performance
Shares of CLX opened at $158.60 on Monday. The company has a 50 day moving average price of $162.76 and a 200-day moving average price of $158.35. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The stock has a market capitalization of $19.63 billion, a PE ratio of 55.26, a PEG ratio of 2.91 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.
Clorox Announces Dividend
Analyst Ratings Changes
CLX has been the topic of a number of research reports. Barclays reduced their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research report on Thursday, January 16th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $156.07.
View Our Latest Stock Analysis on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- What is a buyback in stocks? A comprehensive guide for investors
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.